22-43498317-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001044370.2(MPPED1):c.715G>A(p.Val239Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000206 in 1,535,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001044370.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MPPED1 | NM_001044370.2 | c.715G>A | p.Val239Ile | missense_variant | 5/7 | ENST00000443721.2 | |
MPPED1 | NM_001362786.2 | c.715G>A | p.Val239Ile | missense_variant | 5/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MPPED1 | ENST00000443721.2 | c.715G>A | p.Val239Ile | missense_variant | 5/7 | 2 | NM_001044370.2 | P1 | |
MPPED1 | ENST00000417669.6 | c.715G>A | p.Val239Ile | missense_variant | 5/7 | 5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000283 AC: 43AN: 152164Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000163 AC: 23AN: 140724Hom.: 0 AF XY: 0.000159 AC XY: 12AN XY: 75426
GnomAD4 exome AF: 0.000197 AC: 273AN: 1383050Hom.: 0 Cov.: 30 AF XY: 0.000182 AC XY: 124AN XY: 682454
GnomAD4 genome ? AF: 0.000282 AC: 43AN: 152282Hom.: 0 Cov.: 31 AF XY: 0.000269 AC XY: 20AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | The c.715G>A (p.V239I) alteration is located in exon (coding exon ) of the MPPED1 gene. This alteration results from a G to A substitution at nucleotide position 715, causing the valine (V) at amino acid position 239 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at